DOP2011000364A - Piperidinas sustituidas - Google Patents

Piperidinas sustituidas

Info

Publication number
DOP2011000364A
DOP2011000364A DO2011000364A DO2011000364A DOP2011000364A DO P2011000364 A DOP2011000364 A DO P2011000364A DO 2011000364 A DO2011000364 A DO 2011000364A DO 2011000364 A DO2011000364 A DO 2011000364A DO P2011000364 A DOP2011000364 A DO P2011000364A
Authority
DO
Dominican Republic
Prior art keywords
piperidins
substituted
diseases
treatment
disorders
Prior art date
Application number
DO2011000364A
Other languages
English (en)
Inventor
Eckhard Bender
Dirk Heimbach
Jean Mark Gnoth
Christoph Gerdes
Anja Buchmuller
Susanne Rohrig
Katja Zimmermann
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of DOP2011000364A publication Critical patent/DOP2011000364A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a nuevas piperidinas sustituidas, a procedimientos para su preparación, al uso de las mismas para tratamiento yio profilaxis de enfermedades y al uso de las mismas para la producción de medicamentos para tratamiento yio profilaxis de enfermedades, especialmente de trastornos cardiovasculares y trastornos tumorales.
DO2011000364A 2009-05-27 2011-11-24 Piperidinas sustituidas DOP2011000364A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009022896A DE102009022896A1 (de) 2009-05-27 2009-05-27 Substituierte Piperidine

Publications (1)

Publication Number Publication Date
DOP2011000364A true DOP2011000364A (es) 2012-02-29

Family

ID=42543057

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2011000364A DOP2011000364A (es) 2009-05-27 2011-11-24 Piperidinas sustituidas

Country Status (28)

Country Link
US (2) US20120220563A1 (es)
EP (1) EP2435427A1 (es)
JP (1) JP5718320B2 (es)
KR (1) KR20120044289A (es)
CN (2) CN104744452A (es)
AR (1) AR076692A1 (es)
AU (1) AU2010252345A1 (es)
BR (1) BRPI1012055A2 (es)
CA (1) CA2763400A1 (es)
CL (1) CL2011002965A1 (es)
CO (1) CO6470823A2 (es)
CR (1) CR20110628A (es)
CU (1) CU20110215A7 (es)
DE (1) DE102009022896A1 (es)
DO (1) DOP2011000364A (es)
EA (1) EA201190312A1 (es)
EC (2) ECSP11011483A (es)
GT (1) GT201100300A (es)
IL (1) IL215901A0 (es)
MA (1) MA33290B1 (es)
MX (1) MX2011012505A (es)
PE (1) PE20120934A1 (es)
SG (1) SG175753A1 (es)
TN (1) TN2011000595A1 (es)
TW (1) TW201109326A (es)
UY (2) UY32636A (es)
WO (1) WO2010136144A1 (es)
ZA (1) ZA201108565B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022892A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
MX360706B (es) 2011-10-07 2018-11-14 Takeda Pharmaceuticals Co Compuestos de 1-arilcarbonil-4-oxi-piperidina utiles para el tratamiento de enfermedades neurodegenerativas.
CN109311874B (zh) 2016-04-20 2021-07-30 百时美施贵宝公司 经取代的二环杂环化合物
EA201991095A1 (ru) 2016-11-03 2019-09-30 Бристол-Маерс Сквибб Компани Замещенные азотсодержащие соединения
MX2019014411A (es) 2017-06-01 2020-02-05 Bristol Myers Squibb Co Compuestos que contienen nitrogeno sustituido.
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767144A (en) * 1994-08-19 1998-06-16 Abbott Laboratories Endothelin antagonists
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6403612B2 (en) * 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
MXPA04003480A (es) 2001-10-15 2004-07-30 Janssen Pharmaceutica Nv Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica.
WO2003074495A1 (en) * 2002-03-01 2003-09-12 Smithkline Beecham Corporation Hppars activators
KR20070024639A (ko) 2004-06-24 2007-03-02 인사이트 산 디에고 인코포레이티드 아미도 화합물 및 약제로서의 이의 용도
CN1993128A (zh) * 2004-06-24 2007-07-04 因塞特公司 N－取代的哌啶及它们作为药物的用途
JP2008504279A (ja) 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
BRPI0512535A (pt) 2004-06-24 2008-03-25 Incyte Corp compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
US20060122197A1 (en) 2004-08-10 2006-06-08 Wenqing Yao Amido compounds and their use as pharmaceuticals
JP2007008913A (ja) * 2004-09-17 2007-01-18 Tanabe Seiyaku Co Ltd ピペリジン化合物およびその製法
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004061750A1 (de) * 2004-12-22 2006-07-06 Bayer Healthcare Ag Heteroaryl-substituierte Pyrazoline
EP1931652A2 (en) 2005-09-21 2008-06-18 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2007089683A1 (en) 2006-01-31 2007-08-09 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2007101270A1 (en) 2006-03-02 2007-09-07 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
CA2649677A1 (en) 2006-05-01 2007-11-15 Incyte Corporation Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
CA2706991A1 (en) * 2007-11-30 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituted piperidines
DE102009014484A1 (de) * 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022897A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine

Also Published As

Publication number Publication date
CN104744452A (zh) 2015-07-01
CN102596944A (zh) 2012-07-18
CN102596944B (zh) 2015-08-26
PE20120934A1 (es) 2012-08-01
ECSP11011482A (es) 2011-12-30
EP2435427A1 (de) 2012-04-04
US20120220563A1 (en) 2012-08-30
CO6470823A2 (es) 2012-06-29
CL2011002965A1 (es) 2012-07-06
MX2011012505A (es) 2011-12-14
CA2763400A1 (en) 2010-12-02
ECSP11011483A (es) 2011-12-30
EA201190312A1 (ru) 2012-05-30
AU2010252345A1 (en) 2011-12-08
JP2012528090A (ja) 2012-11-12
TN2011000595A1 (en) 2013-05-24
TW201109326A (en) 2011-03-16
ZA201108565B (en) 2013-01-30
US8084469B2 (en) 2011-12-27
SG175753A1 (en) 2011-12-29
CU20110215A7 (es) 2012-03-15
IL215901A0 (en) 2012-01-31
CR20110628A (es) 2012-03-22
MA33290B1 (fr) 2012-05-02
US20110021489A1 (en) 2011-01-27
BRPI1012055A2 (pt) 2016-05-17
UY32636A (es) 2010-12-31
JP5718320B2 (ja) 2015-05-13
KR20120044289A (ko) 2012-05-07
WO2010136144A1 (de) 2010-12-02
UY32638A (es) 2010-10-29
AR076692A1 (es) 2011-06-29
GT201100300A (es) 2013-08-21
DE102009022896A1 (de) 2010-12-02

Similar Documents

Publication Publication Date Title
DOP2011000364A (es) Piperidinas sustituidas
CL2018000039A1 (es) Derivados de oxopiridina sustituidos
PA8784001A1 (es) Oxazolidinonas sustituidas y su uso
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
PH12015500106A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
MY150748A (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and their use
UY31484A1 (es) Piperidinas heteroaril-sustituidas
IN2012DN02805A (es)
EA201690520A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
SMT201200017B (it) Nuovi antagonisti P2X7R e il loro uso.
ATE523510T1 (de) Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung
CR20140553A (es) Compuestos de fenoxietil piperidina
CO6470822A2 (es) Piperidinas susituidas
MY150931A (en) Substituted oxazolidinones and their use
TN2016000107A1 (en) Substituted phenylalanine derivatives
DE502007006625D1 (de) 3-cyano-5-thiazaheteroaryl-dihydropyridine und ihrnkungen
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
DOP2015000290A (es) Benzoxazoles sustituidos
BR112013006307A2 (pt) fenilacetamidas e fenilpropanamidas substituídas e o seu uso
UA113887C2 (xx) 5-амінотетрагідрохінолін-2-карбонові кислоти і їх застосування
DOP2011000211A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas